[Clinical experience with aspoxicillin in the pediatric field]

Area of Science:

• Pediatric Infectious Diseases
• Bacteriology
• Clinical Pharmacology

Context:

• Acute bacterial infections in children require effective antibiotic treatment.
• Evaluating novel antibiotics is crucial for pediatric care.
• Aspoxicillin (ASPC) is an antibiotic investigated for pediatric use.

Purpose:

• To assess the clinical effectiveness and bacteriological eradication of Aspoxicillin (ASPC) in pediatric patients.
• To document the safety profile of ASPC in a pediatric population.

Summary:

• A study involved 20 children with acute bacterial infections, including bronchopneumonia and urinary tract infections, treated with intravenous Aspoxicillin (ASPC).
• Clinical effectiveness was observed in 70% (14/20) of cases, and bacteriological eradication was achieved in 80% (8/10) of evaluable cases.
• ASPC exhibited a favorable safety profile, with only minor, transient side effects reported in a small number of patients.

Impact:

• Aspoxicillin (ASPC) shows promise as a valuable therapeutic option for bacterial infections in children.
• The findings support the use of ASPC in pediatric clinical practice.
• Further research may explore ASPC's efficacy in a broader range of pediatric bacterial infections.